Heribert Jürgens - Concepedia

Author

Heribert Jürgens

Also Known As

H Jrgens, H Jurgens, H Jürgens, H. Jurgens, H. JÜRGENS, H. JÜRgens, H. Jürgens, H.F. Jürgens, H. Jürgens, Heribert Jurgens

299

Publications

18.3K

Citations

H-Index

112

Concepts

All Affiliations

University Hospital Münster University of Münster Heinrich Heine University Düsseldorf St Anna Children's Hospital Düsseldorf University Hospital

About

Heribert Jürgens is an author at University Hospital Münster specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	54	5.6K
2	Health Sciences	16	16	1.8K
3	Engineering	2	2	491
4	Public Health	1	1	36
5	Allergy	1	1	18

Heribert Jürgens

117

Publications

16.7K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Stefan Bielack, Beate Kempf‐Bielack, G. Delling, Journal of Clinical Oncology	2002	1.8K
Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group Simon Cotterill, S. Ahrens, Michael Paulussen, Journal of Clinical Oncology	2000	1K
Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Leo Kager, A. Zoubek, Ulrike Pötschger, Journal of Clinical Oncology	2003	939
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Pancras C.W. Hogendoorn, Nick Athanasou, S. Bielack, Annals of Oncology Bone SarcomasSurgical OncologyMedicineOrthopaedic SurgeryRadiology	2010	716
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS) Beate Kempf‐Bielack, Stefan Bielack, Heribert Jürgens, Journal of Clinical Oncology Surgical OncologyCombined Modality TherapyOsteosarcoma RelapsePleural DisruptionCancer Recurrence	2005	642
Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial Ruth Ladenstein, Ulrike Pötschger, Marie‐Cécile Le Deley, Journal of Clinical Oncology	2010	528
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial Neyssa Marina, Sigbjørn Smeland, Stefan Bielack, The Lancet Oncology	2016	511
Whole-Body MR Imaging for Detection of Bone Metastases in Children and Young Adults Heike E. Daldrup‐Link, Christiane Franzius, Thomas M. Link, American Journal of Roentgenology	2001	444
Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86 Michael Paulussen, S. Ahrens, Jürgen Dunst, Journal of Clinical Oncology	2001	439
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions Giuliano Ciarimboli, Dirk Deuster, Arne Knief, American Journal Of Pathology Molecular PharmacologyTranslational PharmacologyMediates Cisplatin-induced Oto-Protective InterventionsMedicine	2010	435

Page 1